← Back to Search

High SES/High Supports for Beliefs About Child Development (FSBS Trial)

N/A
Waitlist Available
Led By Dana Suskind, M.D.
Research Sponsored by University of Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Must live in the United States
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at enrollment only
Awards & highlights

FSBS Trial Summary

This study is evaluating whether the type of scenario presented to participants before taking a survey affects how they answer subsequent questions.

FSBS Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

FSBS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at enrollment only
This trial's timeline: 3 weeks for screening, Varies for treatment, and at enrollment only for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Beliefs about the role of parenting and family supports on child development
Secondary outcome measures
Stress and self-efficacy

FSBS Trial Design

4Treatment groups
Experimental Treatment
Group I: Low SES/Low SupportsExperimental Treatment1 Intervention
Participants assigned to the "Low SES/Low Supports" arm will see the "Low SES/Low Supports" intervention
Group II: Low SES/High SupportsExperimental Treatment1 Intervention
Participants assigned to the "Low SES/High Supports" arm will see the "Low SES/High Supports" intervention
Group III: High SES/Low SupportsExperimental Treatment1 Intervention
Participants assigned to the "Low SES/High Supports" arm will see the "High SES/Low Supports" intervention
Group IV: High SES/High SupportsExperimental Treatment1 Intervention
Participants assigned to the "High SES/High Supports" arm will see the "High SES/High Supports" intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
High SES/Low Supports
2021
N/A
~210
Low SES/High Supports
2021
N/A
~210
Low SES/ Low Supports
2021
N/A
~210
High SES/High Supports
2021
N/A
~210

Find a Location

Who is running the clinical trial?

University of ChicagoLead Sponsor
997 Previous Clinical Trials
817,493 Total Patients Enrolled
Dana Suskind, M.D.Principal InvestigatorUniversity of Chicago
1 Previous Clinical Trials

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~56 spots leftby Mar 2025